A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Renaissance Technologies LLC holds 8,112,963 shares of TEVA stock, worth $139 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
8,112,963
Previous 8,728,563 7.05%
Holding current value
$139 Million
Previous $142 Million 3.07%
% of portfolio
0.23%
Previous 0.25%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$15.81 - $18.96 $9.73 Million - $11.7 Million
-615,600 Reduced 7.05%
8,112,963 $146 Million
Q2 2024

Aug 09, 2024

BUY
$12.78 - $17.4 $13.2 Million - $17.9 Million
1,031,400 Added 13.4%
8,728,563 $142 Million
Q1 2024

May 13, 2024

BUY
$10.67 - $14.43 $24.1 Million - $32.6 Million
2,261,800 Added 41.61%
7,697,163 $109 Million
Q4 2023

Feb 13, 2024

BUY
$8.12 - $10.63 $11.5 Million - $15.1 Million
1,417,463 Added 35.28%
5,435,363 $56.7 Million
Q3 2023

Nov 14, 2023

SELL
$7.48 - $10.7 $18.9 Million - $27 Million
-2,522,160 Reduced 38.56%
4,017,900 $41 Million
Q2 2023

Aug 11, 2023

BUY
$7.2 - $9.47 $38,880 - $51,138
5,400 Added 0.08%
6,540,060 $49.2 Million
Q1 2023

May 12, 2023

BUY
$8.36 - $11.37 $16.3 Million - $22.1 Million
1,944,097 Added 42.35%
6,534,660 $57.8 Million
Q4 2022

Feb 13, 2023

BUY
$7.95 - $9.48 $1.99 Million - $2.38 Million
250,563 Added 5.77%
4,590,563 $41.9 Million
Q3 2022

Nov 14, 2022

BUY
$6.86 - $11.95 $1.34 Million - $2.33 Million
195,037 Added 4.71%
4,340,000 $35 Million
Q2 2022

Aug 12, 2022

BUY
$7.38 - $10.4 $11.5 Million - $16.2 Million
1,555,800 Added 60.09%
4,144,963 $31.2 Million
Q1 2022

May 13, 2022

BUY
$7.33 - $9.39 $11.9 Million - $15.2 Million
1,623,966 Added 168.25%
2,589,163 $24.3 Million
Q4 2021

Feb 11, 2022

BUY
$7.9 - $10.19 $7.34 Million - $9.47 Million
929,397 Added 2596.08%
965,197 $7.73 Million
Q3 2021

Nov 12, 2021

SELL
$8.38 - $10.18 $7.63 Million - $9.27 Million
-910,563 Reduced 96.22%
35,800 $349,000
Q2 2021

Aug 13, 2021

BUY
$9.9 - $11.56 $9.37 Million - $10.9 Million
946,363 New
946,363 $9.37 Million
Q4 2020

Feb 10, 2021

SELL
$8.61 - $11.04 $9.81 Million - $12.6 Million
-1,139,163 Closed
0 $0
Q3 2020

Nov 13, 2020

SELL
$8.57 - $12.69 $25.3 Million - $37.5 Million
-2,952,300 Reduced 72.16%
1,139,163 $10.3 Million
Q2 2020

Aug 13, 2020

BUY
$8.12 - $13.12 $7.25 Million - $11.7 Million
892,431 Added 27.9%
4,091,463 $50.4 Million
Q1 2020

May 14, 2020

BUY
$6.69 - $13.45 $6.47 Million - $13 Million
967,036 Added 43.33%
3,199,032 $28.7 Million
Q4 2019

Feb 13, 2020

SELL
$6.53 - $10.72 $30.7 Million - $50.5 Million
-4,706,667 Reduced 67.83%
2,231,996 $21.9 Million
Q3 2019

Nov 13, 2019

SELL
$6.16 - $9.6 $17.5 Million - $27.3 Million
-2,847,400 Reduced 29.1%
6,938,663 $47.7 Million
Q2 2019

Aug 12, 2019

BUY
$8.12 - $15.72 $58.1 Million - $113 Million
7,159,900 Added 272.64%
9,786,063 $90.3 Million
Q1 2019

May 14, 2019

SELL
$15.58 - $20.01 $67.2 Million - $86.4 Million
-4,315,822 Reduced 62.17%
2,626,163 $41.2 Million
Q4 2018

Feb 13, 2019

BUY
$14.59 - $23.84 $101 Million - $165 Million
6,941,985 New
6,941,985 $107 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.